7 results on '"Ji-Hee Sung"'
Search Results
2. Association of adherence to guidelines for cervical cerclage with perinatal outcomes and placental inflammation in women with cervical length ≥2.0 cm
- Author
-
Hyea Park, Do Youn Kwon, Seo-yeon Kim, Juyoung Park, Yoo-min Kim, Ji-Hee Sung, Suk-Joo Choi, Soo-young Oh, Jung-Sun Kim, and Cheong-Rae Roh
- Subjects
Uterine cervical incompetence ,Cerclage ,Guideline ,Pregnancy outcomes ,Chorioamnionitis ,Gynecology and obstetrics ,RG1-991 - Abstract
Objectives: Cerclage operation is one of the most common obstetric controversies. The aim of this study was to compare the perinatal outcomes and placental inflammation of cerclage performed adherent and non-adherent to international guidelines. Material and methods: This study included all consecutive women with singleton deliveries who underwent cerclage. According to the current American College of Obstetricians and Gynecologists (ACOG) guideline, we designated our study population into two groups: the adherent-to-guideline and non-adherent groups. Each group was categorized into two groups according to cervical length (CL) at the time of cerclage (
- Published
- 2021
- Full Text
- View/download PDF
3. Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID)
- Author
-
In Kyung Hong, Min-Jung Kwon, Su Hyun Nam, Kye Hyun Kim, Kyo Won Lee, Ji-Hee Sung, and Taejong Song
- Subjects
Pelvic inflammatory disease ,Tuboovarian abscess ,Procalcitonin ,C-reactive protein ,Gynecology and obstetrics ,RG1-991 - Abstract
Objective: This study aimed to investigate the value of serum procalcitonin as an early predictor of antibiotic treatment response in the inpatient management of pelvic inflammatory disease (PID). Materials and methods: A prospective observational study was carried out at a university hospital. Patients admitted for pelvic inflammatory disease were classified into 2 groups: responders and non-responders. The primary outcome measure was the serum level of procalcitonin at the time of admission. The secondary outcome measures were other serum inflammatory markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell (WBC) count. Results: Baseline characteristics were similar between the groups. Serum level of procalcitonin at the time of admission did not differ between the groups (P = 0.564). However, the non-responders had more elevated CRP and ESR compared to the responders (P = 0.045 and P = 0.030, respectively). CRP showed the highest accuracy of 72.1% (95% confidence interval [CI], 59.2 to 82.9) in predicting antibiotics response, while procalcitonin showed the lowest accuracy of 49.1% (95% CI, 35.1 to 63.2). Conclusion: Compared with standard inflammatory markers such as CRP or ESR, procalcitonin had limited diagnostic value in predicting antibiotics response in patients admitted for PID. Therefore, procalcitonin measurement cannot be recommended as a laboratory test for patients with PID and the value of its routine use remains inconclusive.
- Published
- 2020
- Full Text
- View/download PDF
4. Uterine wall thickness at the second trimester can predict subsequent preterm delivery in pregnancies with adenomyosis
- Author
-
Yoo-Min Kim, Soo Hyun Kim, Ji-Hye Kim, Ji-Hee Sung, Suk-Joo Choi, Soo-young Oh, and Cheong-Rae Roh
- Subjects
Gynecology and obstetrics ,RG1-991 - Abstract
Objectives: We assessed the usefulness of ultrasonography (USG) findings of adenomyosis during pregnancy in the prediction of subsequent preterm delivery. Materials and methods: We included consecutive pregnant women who underwent first trimester ultrasonography in our institution, confirmed as having adenomyosis and subsequently delivered in our institution from January 2006 to April 2018. The subjects were classified into two groups: preterm delivery group and term delivery group. Information of maximal uterine wall thickness measured at first trimester and second trimester, maternal characteristics, pregnancy outcomes, and neonatal outcomes were reviewed and compared between preterm and term delivery group. Results: A total of 57 pregnancies were included in this study, and 14 women (24.5%) delivered before 37 weeks of pregnancy. The women from the preterm delivery group had a significantly thicker uterine wall during the second trimester of pregnancy compared to the women from the term delivery group (4.49 ± 1.62 cm vs. 3.05 ± 1.6 cm, p = 0.004). From the first trimester to the second trimester of pregnancy, uterine wall thickness showed a significantly smaller decrease in the preterm delivery group than the term delivery group (−0.42 ± 0.93 cm vs. −1.04 ± 0.89 cm, p = 0.02). By receiver operating characteristics (ROC) curve analysis, uterine wall thickness greater than 4.6 cm in the second trimester of pregnancy showed 57.1% sensitivity, 86.1% specificity, 57.1% positive predictive value (PPV) and 86.1% negative predictive value (NPV) for subsequent preterm delivery (area under curve = 0.758). Conclusions: Uterine wall thickness measurement in second trimester can help to identify preterm delivery in pregnant women with adenomyosis. Keywords: Adenomyosis, Preterm delivery, Ultrasonography
- Published
- 2019
- Full Text
- View/download PDF
5. Amniopatch treatment for preterm premature rupture of membranes before 23 weeks' gestation and factors associated with its success
- Author
-
Ji-Hee Sung, Jin-Yi Kuk, Hyun-Hwa Cha, Suk-Joo Choi, Soo-young Oh, Cheong-Rae Roh, and Jong-Hwa Kim
- Subjects
Amniopatch ,Iatrogenic preterm premature rupture of membranes ,Before 23 weeks' gestation ,Spontaneous preterm premature rupture of membranes ,Gynecology and obstetrics ,RG1-991 - Abstract
Objective: The purpose of this study is to investigate the factors associated with successful amniopatch treatment in patients with iatrogenic preterm premature rupture of membranes (iPPROM) or spontaneous PPROM (sPPROM) before 23 weeks' gestation. Materials and methods: This cohort study included 28 women who received amniopatch treatment due to iPPROM or sPPROM at 15–23 weeks' gestation. Patients' clinical characteristics before performing the amniopatch, factors associated with the procedure, pregnancy and neonatal outcomes were compared between the iPPROM and sPPROM groups, and also between the successful and failed groups. Results: The amniopatch was successful in 6 of 28 patients (21.4%) with a success rate of 36.4% (4/11) and 11.8% (2/17) in the iPPROM group and sPPROM group (P = 0.174), respectively. The success group had a longer PPROM-to-delivery interval, fewer cases of clinical chorioamnionitis, larger birth weight, and lower neonatal intensive care unit admission rate than the failed group. The success rate of amniopatch procedure was proportional to maximal vertical pocket prior to procedure, which showed statistically significant association (adjusted odds ratio: 3.62, 95% confidence interval: 1.16–11.31, P = 0.027). Conclusion: The amniopatch treatment success rate was higher in the iPPROM group than the sPPROM group, but was not statistically significant. The neonatal outcome was more favorable when the amniopatch was successful. However, the only predictive factor associated with successful amniopatch was a larger amniotic fluid volume before the procedure.
- Published
- 2017
- Full Text
- View/download PDF
6. Maternal pre-pregnancy body mass index and the risk for gestational diabetes mellitus in women with twin pregnancy in South Korea
- Author
-
Soo-young Oh, Suk-Joo Choi, Seo-Yeon Kim, Sir-Yeon Hong, Do Youn Kwon, Hyea Park, Ji-Hee Sung, Cheong-Rae Roh, and Yejin Kim
- Subjects
medicine.medical_specialty ,Twin pregnancy ,Twins ,Overweight ,Gestational diabetes mellitus ,Thinness ,Pregnancy ,Risk Factors ,Republic of Korea ,medicine ,Humans ,Obesity ,Twin Pregnancy ,Body mass index ,Retrospective Studies ,business.industry ,Obstetrics ,Pregnancy Outcome ,Obstetrics and Gynecology ,nutritional and metabolic diseases ,Gynecology and obstetrics ,medicine.disease ,Gestational diabetes ,Diabetes, Gestational ,Pregnancy, Twin ,RG1-991 ,Population study ,Female ,Underweight ,medicine.symptom ,business - Abstract
Objective: To investigate the association between maternal pre-pregnancy body mass index (BMI) and the risk for gestational diabetes mellitus (GDM) in women with twin pregnancy in South Korea. Materials and methods: We performed a single-center, retrospective cohort study involving 1028 women with twin pregnancy from January 2006 to December 2018 in South Korea. Pregnancies with monoamnionic twins, twin–twin transfusion syndrome, fetal death in utero before 24 weeks, pre-gestational diabetes mellitus, and unknown BMI or GDM status were excluded. Subjects were grouped into four groups based on pre-pregnancy BMI: underweight (
- Published
- 2021
7. Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID)
- Author
-
Taejong Song, Kyo Won Lee, Ji-Hee Sung, In Kyung Hong, Kye Hyun Kim, Min-Jung Kwon, and Su Hyun Nam
- Subjects
Adult ,medicine.medical_specialty ,medicine.drug_class ,Antibiotics ,Gastroenterology ,lcsh:Gynecology and obstetrics ,Procalcitonin ,C-reactive protein ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,White blood cell ,Internal medicine ,Pelvic inflammatory disease ,medicine ,Humans ,Prospective Studies ,lcsh:RG1-991 ,030219 obstetrics & reproductive medicine ,medicine.diagnostic_test ,biology ,business.industry ,Obstetrics and Gynecology ,Confidence interval ,Anti-Bacterial Agents ,medicine.anatomical_structure ,Case-Control Studies ,Erythrocyte sedimentation rate ,biology.protein ,Female ,Tuboovarian abscess ,business ,Procalcitonin Measurement ,Biomarkers - Abstract
Objective This study aimed to investigate the value of serum procalcitonin as an early predictor of antibiotic treatment response in the inpatient management of pelvic inflammatory disease (PID). Materials and methods A prospective observational study was carried out at a university hospital. Patients admitted for pelvic inflammatory disease were classified into 2 groups: responders and non-responders. The primary outcome measure was the serum level of procalcitonin at the time of admission. The secondary outcome measures were other serum inflammatory markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell (WBC) count. Results Baseline characteristics were similar between the groups. Serum level of procalcitonin at the time of admission did not differ between the groups (P = 0.564). However, the non-responders had more elevated CRP and ESR compared to the responders (P = 0.045 and P = 0.030, respectively). CRP showed the highest accuracy of 72.1% (95% confidence interval [CI], 59.2 to 82.9) in predicting antibiotics response, while procalcitonin showed the lowest accuracy of 49.1% (95% CI, 35.1 to 63.2). Conclusion Compared with standard inflammatory markers such as CRP or ESR, procalcitonin had limited diagnostic value in predicting antibiotics response in patients admitted for PID. Therefore, procalcitonin measurement cannot be recommended as a laboratory test for patients with PID and the value of its routine use remains inconclusive.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.